Meanwhile, a previous study has reported that reduced BDNF has been implicated in depression, and fluoxetine, a selective serotonin-uptake inhibitor, exerts antidepressant effects through the ERK-CREB signaling system [47]. The gene discussed is CREB1; the disease is depressive symptom measurement.